LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
0.80
-0.02 (-2.44%)
At close: Aug 20, 2025, 12:28 PM
LakeShore Biopharma Ltd Cash Flow Statement
Financials in CNY. Fiscal
year is
April - March.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -181.41M | -77.62M | -105.02M | -69.42M | -111.07M | -88.71M | -29.25M | 11.52M | 45.27M | 19.74M | 6.68M | -30.24M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 9.8M | n/a | n/a | n/a | 3.51M | 84.76K | -85.64K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.05M | 436.57K | 714.43K | -3.75M | n/a |
Other Non-Cash Items | 171.61M | 77.62M | 105.02M | 69.42M | 107.56M | 88.63M | 29.34M | -14.26M | -46.76M | -21.66M | -7.98M | 32.58M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.05M | 436.58K | 714.43K | -3.75M | n/a |
Operating Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -693.96K | -1.05M | -1.2M | -5.06M | 2.34M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 734.02K | 1.43M | -1.29B |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 734.02K | 1.43M | -1.29B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.32K | -1.42M | 21.97M |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -739.52K | -1.45M | 1.3B |
Net Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -698.7K | -1.05M | -1.21M | -5.06M | 12.02M |
Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -693.96K | -1.05M | -1.2M | -5.06M | 2.34M |